Also known as type 1.5 diabetes, here’s what to know about the onset, symptoms, diagnosis, and treatment options for latent ...

Recent cuts to federal grants are set to have a widespread impact across numerous scientific and medical studies.

GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.

According to a study published in JAMA Network Open, among patients with type 2 diabetes (T2D), the use of glucagon-like ...

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...